Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma of large intestine
|
432 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
374 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
370 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
373 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
368 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||
Colorectal Carcinoma
|
1962 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||
Colorectal Neoplasms
|
609 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||
Malignant neoplasm of large intestine
|
375 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||
Malignant tumor of colon
|
688 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||
Adenoma of large intestine
|
213 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||
Chronic osteomyelitis
|
12 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.700 | 0 | ||||||||
Breast Carcinoma
|
2793 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.030 | 0.333 | 3 | 2017 | 2019 | |||||
Malignant neoplasm of breast
|
3417 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.030 | 0.333 | 3 | 2017 | 2019 | |||||
Carcinoma of lung
|
1204 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.020 | 1.000 | 2 | 2009 | 2015 | |||||
Malignant neoplasm of lung
|
1142 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.020 | 1.000 | 2 | 2009 | 2015 | |||||
Primary malignant neoplasm of lung
|
981 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.020 | 1.000 | 2 | 2009 | 2015 | |||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Diabetes Mellitus
|
824 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant neoplasm of stomach
|
615 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||
Malignant Neoplasms
|
1641 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Neoplasms
|
1644 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Peripheral Arterial Diseases
|
128 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Primary malignant neoplasm
|
1374 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Stomach Carcinoma
|
652 | 0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 | 0.010 | 1.000 | 1 | 2016 | 2016 |